Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study

Roland Stocker; Christine Pollicino; Craig Gay; Paul Nestel; David Colquhoun; Malcolm Whiting; Andrew Tonkin; David Sullivan; John Simes

Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study

Roland Stocker, Christine Pollicino, Craig Gay, Paul Nestel, David Colquhoun, Malcolm Whiting, Andrew Tonkin, David Sullivan, John Simes

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Original language	English
Article number	CC
Pages (from-to)	198-204
Number of pages	7
Journal	Atherosclerosis
Volume	187
Issue number	1
Publication status	Published - 2006

Cite this

Stocker, Roland ; Pollicino, Christine ; Gay, Craig ; Nestel, Paul ; Colquhoun, David ; Whiting, Malcolm ; Tonkin, Andrew ; Sullivan, David ; Simes, John. / Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. In: Atherosclerosis. 2006 ; Vol. 187, No. 1. pp. 198-204.

@article{de64872a19b947b4af88d6d50fc64582,

title = "Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study",

author = "Roland Stocker and Christine Pollicino and Craig Gay and Paul Nestel and David Colquhoun and Malcolm Whiting and Andrew Tonkin and David Sullivan and John Simes",

year = "2006",

language = "English",

volume = "187",

pages = "198--204",

journal = "Atherosclerosis",

issn = "0021-9150",

number = "1",

}

Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. / Stocker, Roland; Pollicino, Christine; Gay, Craig; Nestel, Paul; Colquhoun, David; Whiting, Malcolm; Tonkin, Andrew; Sullivan, David; Simes, John.

In: Atherosclerosis, Vol. 187, No. 1, CC, 2006, p. 198-204.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study

AU - Stocker, Roland

AU - Pollicino, Christine

AU - Gay, Craig

AU - Nestel, Paul

AU - Colquhoun, David

AU - Whiting, Malcolm

AU - Tonkin, Andrew

AU - Sullivan, David

AU - Simes, John

PY - 2006

Y1 - 2006

M3 - Article

VL - 187

SP - 198

EP - 204

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

M1 - CC

ER -